Parkinson’s Resource Organization (PRO) and The Michael J. Fox Foundation (MJFF), collaborating for the first time, will present “Parkinson’s Today: An Educational Symposium” on Feb. 8 for residents ...

Two proteins found on the surface of motor neurons in the brain may be essential in the progression of Parkinson's disease, ...

ST. LOUIS--(BUSINESS WIRE)--A respected organization acclaimed for their groundbreaking work with neurological diseases, C2N Diagnostics, LLC, is partnering with The Michael J. Fox Foundation For ...

This therapy is one of a few drugs in mid-to-late-stage development for Parkinson’s that has displayed disease-modifying potential.

SUGAR LAND, Texas--(BUSINESS WIRE)--Houston-area clinical research organization Hope Biosciences Research Foundation (HBRF) today shares positive top-line results of a Phase II clinical trial to ...

THAT’S WHAT ONE FOUNDATION STRIVES FOR HERE IN SACRAMENTO TODAY. 400 PEOPLE CAME OUT TO SUPPORT THOSE AFFECTED BY PARKINSON’S DISEASE. THIS IS THE EIGHTH YEAR OF THE COMMUNITY EVENT. IT TOOK PLACE AT ...

The Michael J. Fox Foundation for Parkinson’s Research held its fourth annual “It Will Take All of Us to Cure Parkinson’s” luncheon, raising over $975,000. MJFF co-founder and CEO Deborah W. Brooks ...

RaceTrac has raised more than $9 million for the Michael J. Fox Foundation since 2011. The fundraiser is personal to RaceTrac, as family members of the company's chief brand officer have been affected ...

Joan Samuelson, a longtime Healdsburg resident who led fight for greater research into a cure for Parkinson’s disease since ...

The founder of the Adewunmi Desalu Parkinson’s Foundation (ADPF), Mrs. Omorinsojo Desalu has said that Parkinson’s disorder is no longer a condition affecting only the elderly. She said that young ...

Parkinson’s disease is a neurodegenerative disorder that causes a gradual loss of brain nerve cells, which produce a chemical messenger called dopamine. Dopamine relays signals throughout the brain ...

Houston-area clinical research organization Hope Biosciences Research Foundation (HBRF) today shares positive top-line results of a Phase II clinical trial to evaluate Hope Biosciences' allogeneic ...